| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/05/1998 | US5747654 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 05/05/1998 | US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
| 05/05/1998 | US5747539 Fluorine-containing benzoylguanidines |
| 05/05/1998 | US5747534 Lobaplatin trihydrate |
| 05/05/1998 | US5747530 Aromatic dibenzofuran compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/05/1998 | US5747529 Antitumor agents |
| 05/05/1998 | US5747514 Metalloproteinase inhibitors |
| 05/05/1998 | US5747499 Cyclopentaquinazoline compounds cyclopentaquinazoline compounds |
| 05/05/1998 | US5747475 Chitosan-derived biomaterials |
| 05/05/1998 | US5747472 Anticarcinogenic agents and antitumor agents |
| 05/05/1998 | US5747469 Methods and compositions comprising DNA damaging agents and p53 |
| 05/05/1998 | US5747458 Plasminogen activator of protease and tripeptides |
| 05/05/1998 | US5747457 Linear adhesion inhibitors |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747303 Intermediates of peptide antagonists of neurotensin |
| 05/05/1998 | US5747269 Determination of peptide motifs on MHC molecules |
| 05/05/1998 | US5747250 Probe for tumour diagnostics or tumour therapy |
| 05/05/1998 | US5747043 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic composition or food composition containing such an extract |
| 05/05/1998 | US5747023 Cancer therapy using lymphotoxin |
| 05/05/1998 | US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 05/05/1998 | CA2073567C Spicamycin derivatives and the use thereof |
| 05/05/1998 | CA1339853C Sf-25 colon adenocarcinoma antigen, and antibodies which recognize thisantigen |
| 04/30/1998 | WO1998017817A1 Retroviral vectors |
| 04/30/1998 | WO1998017814A2 Gene expression and delivery systems and uses |
| 04/30/1998 | WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | WO1998017806A1 Mini-e1a genes and gene products |
| 04/30/1998 | WO1998017801A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-α NUCLEIC ACIDS |
| 04/30/1998 | WO1998017799A1 Immunotherapy and improved vaccines |
| 04/30/1998 | WO1998017798A1 Placental-derived prostate growth factors |
| 04/30/1998 | WO1998017797A1 ANTI-ErbB2 ANTIBODIES |
| 04/30/1998 | WO1998017794A1 Human eosinophil-derived basic protein |
| 04/30/1998 | WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | WO1998017655A1 Metalloproteinase inhibitors |
| 04/30/1998 | WO1998017650A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
| 04/30/1998 | WO1998017649A1 Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide |
| 04/30/1998 | WO1998017648A1 Anthranilic acid derivatives as multi drug resistance modulators |
| 04/30/1998 | WO1998017645A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS |
| 04/30/1998 | WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 04/30/1998 | WO1998017624A1 Conformationally restricted polyamines and their use as antineoplastic agents |
| 04/30/1998 | WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 04/30/1998 | WO1998017302A1 Total synthesis of the amino hip analogue of didemnin a |
| 04/30/1998 | WO1998017300A1 Mucin-mediated immunomodulation |
| 04/30/1998 | WO1998017275A1 Semi-synthetic studies toward didemnin analogues |
| 04/30/1998 | WO1998017269A1 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 04/30/1998 | WO1998017116A1 Targeted cytotoxic cells |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | CA2751712A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2745736A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2271721A1 Mini-e1a genes and gene products |
| 04/30/1998 | CA2269881A1 Semi-synthetic studies toward didemnin analogues |
| 04/30/1998 | CA2269878A1 Total synthesis of the amino hip analogue of didemnin a |
| 04/30/1998 | CA2269507A1 Targeted cytotoxic cells |
| 04/30/1998 | CA2269349A1 Mucin-mediated immunomodulation |
| 04/30/1998 | CA2269283A1 Metalloproteinase inhibitors |
| 04/30/1998 | CA2269100A1 Methods and compositions for delivery and expression of interferon-.alpha. nucleic acids |
| 04/30/1998 | CA2269074A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2268746A1 Placental-derived prostate growth factors |
| 04/30/1998 | CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | CA2268418A1 .alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/30/1998 | CA2268413A1 Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide |
| 04/30/1998 | CA2268276A1 Gene expression and delivery systems and uses |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | CA2268016A1 Human eosinophil-derived basic protein |
| 04/30/1998 | CA2219377A1 Improvements in or relating to the prophylaxis of breast cancer |
| 04/29/1998 | EP0838462A1 Benzothiophene compounds, intermediates, compositions, and methods |
| 04/29/1998 | EP0838461A2 Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity |
| 04/29/1998 | EP0838459A1 Naphthyl compounds, compositions, and methods |
| 04/29/1998 | EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/29/1998 | EP0838221A1 Lyophilized hgf preparations |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837932A1 Macrophage activating factors derived from cloned vitamin d binding protein |
| 04/29/1998 | EP0837927A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
| 04/29/1998 | EP0837878A1 Antitumor proteins from rana pipiens oocytes |
| 04/29/1998 | EP0837861A1 New pyrido-thiopyranoindazoles with antitumor activity |
| 04/29/1998 | EP0837848A1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 04/29/1998 | EP0837839A2 9-substituted porphycenes |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837687A1 Hapten modified tumor cell extract and methods of treating or screening for cancer |
| 04/29/1998 | EP0837683A1 Preparation and use of sulfated oligosaccharides |
| 04/29/1998 | EP0837630A1 Prodrugs of pharmaceuticals with improved bioavailability |
| 04/29/1998 | EP0720597B1 Triaryl-ethylene derivatives for use in therapy |
| 04/29/1998 | EP0664704B1 Use of dopamine agonists to activate gamma-interferon production |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180358A Bridged indoles as matrix metalloprotease inhibitors |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1179974A Drug for curing lung cancer |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744623 Terpene-quinones with antitumour activity |
| 04/28/1998 | US5744592 Improving the bioavailability and absorption of a drug through the digestive tract by covalently bonding the drug and a 1-o-or-s-alkyl-sn-glycero-3-phosphate |
| 04/28/1998 | US5744580 Fusion protein |
| 04/28/1998 | US5744499 Apoptosis-modulating factors influencing the intracellular concentration of methional/malondialdehyde |
| 04/28/1998 | US5744497 Trinuclear cationic platinum complexes having antitumor activity and pharmaceutical compositions containing them |
| 04/28/1998 | US5744362 Antisense oligonucleotide modulation of raf gene expression |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744159 Plasmid entrapping multilamellar liposomes |
| 04/28/1998 | US5744144 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 04/28/1998 | US5744142 Self-assembling recombinant papillomavirus capsid proteins |